XtalPi Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States201-500 Employees
XtalPi Inc. is a biotechnology research company specializing in AI- and quantum physics-informed drug discovery and development. It operates an integrated platform that combines cloud-based in silico tools with robotic automation in a wet lab, enabling an iterative feedback loop between dry lab calculations and experimental work. The company is headquartered in Cambridge, Massachusetts, at 245 Main Street, 11th Floor, and employs between 201 and 500 people with operations in both the United States and China. XtalPi went public in Hong Kong in June 2024, reflecting its market presence. Its activity includes partnerships and acquisitions across its AI-driven drug discovery platform, such as collaborations with PharmaEngine and Kula Bio, an integration with Sinar Mas, an AWS partnership, and the acquisition of Liverpool ChiroChem.